Treatment and Management of Hypersensitivity Reactions Developed Against Anti-Tuberculosis Drug
International Journal Of MycobacteriologyPeer ReviewedZeynep Yegin Katran +32022Journals
The World Health Organization Global Tuberculosis Report 2021 defines tuberculosis as the second infectious disease that causes sickness and death after COVID 19 and ranks it as the 13 h among the global causes of death. However, the prevalence of the patients developing a hypersensitivity reaction against antituberculosis treatment is yet unknown. This study aimed to investigate the prevalence of drug allergy against antituberculosis treatment and the management of such a problem.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support